[National guidelines for lipid management in primary diabetic patients (2025)].

In patients with diabetes, dyslipidemia plays a crucial role in the development and progression of atherosclerotic cardiovascular disease (ASCVD), and what's more, diabetes is a significant independent risk factor for ASCVD. Currently, in China, the rate of dyslipidemia among patients with diabetes is high, while the control rate remains low. Therefore, it is essential to screen for dyslipidemia and enhance its management in patients with diabetes at the primary care level. This guideline includes the following: basic requirements for the management of dyslipidemia, lipid testing items, management goals, lipid-lowering strategies and referral criteria. It aims to provide comprehensive guidance for the management of dyslipidemia in patients with diabetes at the primary care level.